Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 74, Issue 12, 2011, Pages 757-768

  Chen, Jianmin ^a   Saggar, Jasdeep K ^a   Ward, Wendy E ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LINSEED OIL; SECOISOLARICIRESINOL; SECOISOLARICIRESINOL DIGLUCOSIDE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; BONE STRENGTH; BREAST CANCER; FEMALE; FEMUR; FOOD INTAKE; HUMAN; HUMAN CELL; LINSEED; LUMBAR VERTEBRA; MOUSE; NONHUMAN; ORGAN WEIGHT; OVARIECTOMY; PRIORITY JOURNAL; UTERUS WEIGHT; WEIGHT GAIN;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; FLAX; HUMANS; LIGNANS; LINSEED OIL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; OVARIECTOMY; TAMOXIFEN;

MUS;

EID: 79956369901     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2011.567950     Document Type: Article

References (61)

1. Adlercreutz, H. 2007. Lignans and human health. Crit. Rev. Clin. Lab. Sci. 44:483-525. (Pubitemid 47619399)
2. Albertazzi, P., and Coupland, K. 2002. Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 42:13-22. (Pubitemid 34521717)
3. Almeida, M., Ambrogini, E., Han, L., Manolagas, S. C., and Jilka, R. L. 2009. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferatoractivated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J. Biol. Chem. 284:27438-27448.
4. Baber, R., Hickey, M., and Kwik, M. 2005. Therapy for menopausal symptoms during and after treatment for breast cancer: Safety considerations. Drug. Safety 28:1085-1100. (Pubitemid 41776000)
5. Bitto, A., Polito, F., Squadrito, F., Marini, H., D'Anna, R., Irrera, N., Minutoli, L.,Granese, R., and Altavilla, D. 2010. Genistein aglycone: A dual mode of action antiosteoporotic soy isoflavone rebalancing bone turnover towards bone formation. Curr. Med. Chem. 17:3007-3018.
6. Boon, H. S., Olatunde, F., and Zick, S. M. 2007. Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005. BMC Womens Health 7:4-10.
7. Bougnoux, P., and Chajes, V. 2003. Alphalinolenic acid and cancer. In Flaxseed in human nutrition, 2nd ed., ed. L. U. Thompson and S. C. Cunnane, 232-244. Champaign IL: AOCS Press.
8. Champaign, IL: AOCS Press. Brenna, J. T., Salem, N., Jr., Sinclair, A. J., and Cunnane, S. C. 2009. aα-Linolenic acid supplementation and conversion to n-3 longchain polyunsaturated fatty acids in humans. Prostaglandins Leukotrienes Essential Fatty Acids 80:85-91.
9. Brooks, J. D., and Thompson, L. U. 2005. Mammalian lignans and genistein decrease the activities of aromatase and 17â-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid. Biochem. Mol. Biol. 94:461-467. (Pubitemid 40616407)
10. Brooks, J. D., Ward, W. E., Lewis, J. E., Hilditch, J., Nickell, L., Wong, E., and Thompson, L. U. 2004. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am. J.Clin. Nutr. 79:318-325. (Pubitemid 41095987)
11. Burdge, G. C., and Calder, P. C. 2005. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev. 45:581-597. (Pubitemid 41511883)
12. Canadian Council on Animal Care. 1993. Guide to the care and use of experimental animals, Vol. 1, 2nd ed. Ottawa: CCAC.
13. Chen, J., Hui, E., Ip, T., and Thompson, L. U. 2004. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (MCF-7) in nude mice. Clin. Cancer. Res. 10:7703-7711.
14. Chen, J., Power, K. A., Mann, J., Cheng, A., and Thompson, L. U. 2007a. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp. Biol. Med. 232:1071-1080. (Pubitemid 47358190)
15. Chen, J., Power, K. A., Mann, J., Cheng, A., and Thompson, L. U. 2007b. Dietary faxseed interaction with tamoxifen induced tumor regression in nude mice with MCF-7 xenografts by down-regulating the expression of estrogen related gene products and signal transduction pathways. Nutr. Cancer. 58:162-170. (Pubitemid 47328768)
16. Chien, A. J., and Goss, P. E. 2006. Aromatase inhibitors and bone health in women with breast cancer. J. Clin. Oncol. 24: 5305-5312. (Pubitemid 46631378)
17. Cornish, S. M., and Chilibeck, P. D. 2009. Alpha-linolenic acid supplementation and resistance training in older adults. Appl. Physiol. Nutr. Metab. 34:49-59.
18. Cunnane, S.C. 2003. Dietary sources and metabolism of α-linolenic acid. In Flaxseed in human nutrition, 2nd ed., ed. L. U. Thompson and S. C. Cunnane, 63.91. Champaign, IL: AOCS Press.
19. Dodin, S., Lemay, A., Jacques, H., Legare, F., Forest, J. C., and Masse, B. 2005. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: A randomized, double-blind, wheat germ placebocontrolled clinical trial. J. Clin. Endocrinol. Metab. 90:1390-1397. (Pubitemid 40463994)
20. Eastell, R., Adams, J. E., Coleman, R. E., Howell, A., Hannon, R. A., Cuzick, J., Mackey, J. R., Beckmann, M. W., and Clack, G. 2008. Effect of anastrozole on bone mineral density: 5-Year results from the anastrozole, tamoxifen, alone or in combination trial. J. Clin. Oncol. 26:1051-1057.
21. Gao, Q., and Horvath, T. L. 2008. Cross-talk between estrogen and leptin signaling in the hypothalamus. Am. J. Physiol. Endocrinol. Metab. 294:E817-E826.
22. Gerster, H. 1998. Can adults adequately convert α-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int. J. Vit. Nutr. Res. 68:159-173. (Pubitemid 28259765)
23. Hardman, W. E. 2002. Omega-3 fatty acids to augment cancer therapy. J. Nutr 132 (suppl.): 3508S-3512S. (Pubitemid 35315828)
24. Jordan, V. C. 2001. The past, present, and future of selective estrogen receptor modulation. Ann. NY Acad. Sci. 949:72.-79. (Pubitemid 34059963)
25. Kaludjerovic, J., and Ward, W. E. 2009. Neonatal exposure to daidzein, genistein, or the combination modulates bone development in female CD-1 mice. J. Nutr. 139:467-473.
26. Kaludjerovic, J., and Ward, W. E. 2010. Neonatal administration of isoflavones attenuates deterioration of bone tissue in female but not male mice. J. Nutr. 140:766-772.
27. Kitts, D. D., Yuan, Y. V., Wijewickreme, A. N., and Thompson, L. U. 1999. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol. Cel. Biochem. 202:91-100. (Pubitemid 30099742)
28. Kotake, S., Nanke, Y., Yago, T., Kawamoto, M., and Yamanaka, H. 2009. Human osteoclastogenic T cells and human osteoclastology. Arthritis. Rheum. 60:3158-3163.
29. Kristensen, B., Ejlertsen, B., Dalgaard, P., Larsen, L., Holmegaard, S. N., Transbol, I., and Mouridsen, H. T. 1994. Tamoxifen and bone metabolism in postmenopausal lowrisk breast cancer patients: A randomized study. J. Clin. Oncol. 12:992-997. (Pubitemid 24145328)
30. Lau, B. Y., Ward, W. E., Kang, J. X., and Ma, D. W. 2009. Femur EPA and DHA are correlated with femur biomechanical strength in young fat-1 mice. J. Nutr. Biochem. 20:453-461.
31. Li, Y., Seifert M.F. Lim, S.Y. Salem Jr, N., Watkins, B.A. 2010. Bone mineral content is positively correlated to n-3 fatty acids in the femur of growing rats. Br. J. Nutr. 104:674-685.
32. Lotinun, S., Westerlind, K.C., Kennedy, A.M., and Turner, R.T. 2003. Comparative effects of long-term continuous release of 16 alpha-hydroxyestrone and 17 betaestradiol on bone, uterus, and serum cholesterol in ovariectomized adult rats. Bone 33:124-131. (Pubitemid 36952694)
33. MacGregor, J. I., and Jordan, V. C. 1998. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50:151-196. (Pubitemid 28305723)
34. Perez, E. A. 2007. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Ann. Oncol. 18 (suppl. 8): viii26-35.
35. Poulsen, R. C., and Kruger, M. C. 2006. Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukotrienes Essential Fatty Acids 75:419-427. (Pubitemid 44648738)
36. Power, K. A., Ward, W. E., Chen, J. M., Saarinen, N. M., and Thompson, L. U. 2007. Flaxseed and soy protein isolate, alone and in combination, differ in their effect on bone mass, biomechanical strength, and uterus in ovariectomized nude mice with MCF-7 human breast tumor xenografts. J. Toxicol. Environ. Health A 70:1888-1896. (Pubitemid 350034912)
37. Powles, T.J., Hickish, T., Kanis, J.A., Tidy, A., and Ashley, S. 1996. Effect of tamoxifen on bone mineral density measured by dualenergy X-ray absorptiometry in healthy premenopausal and postmenopausal women. J. Clin. Oncol. 14:78-84. (Pubitemid 26022463)
38. Prasad, K. 1997. Hydroxyradical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Mol. Cell Biochem. 168:117-123 (Pubitemid 27091062)
39. Prasad, K. 2000a. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, coisolariciresinol, enterodiol, and enterolactone. Int. J. Angiol. 9:220-225.
40. Prasad, K. 2000b. Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG). Mol. Cell Biochem. 219:89-96. (Pubitemid 30451439)
41. Rausch, S. M., Winegardner, F., Kruk, K. M., Phatak, V.,Wahner-Roedler, D. L., Bauer, B., and Vincent, A. 2011. Complementary and alternative medicine: Use and disclosure in radiation oncology community practice. Support Care Cancer.19: 521-529.
42. Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. 1993. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:1939-1951. (Pubitemid 23342492)
43. Reid, D. M. 2009. Prevention of osteoporosis after breast cancer. Maturitas 64:4-8.
44. Rickard, S. E., Orcheson, L. J., Seidl, M. M., Luyengi, L., Fong, H. H., and Thompson, L. U. 1996. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J. Nutr. 126:2012-2019. (Pubitemid 26260223)
45. Rickard, S. E., and Thompson, L. U. 1998. Chronic exposure to SDG alters lignin disposition in rats. J. Nutr. 128:615-623.
46. Sacco, S. M., Thompson, L. U., and Ward, W. E. 2010. Combination of flaxseed and low dose estrogen therapy on bone healthin arat model of postmenopausal osteoporosis. Proc. US Flax Institute, ed. J. Hammond, 16-21. Fargo: North Dakota State University.
47. Sacco, S. M., Jiang, J. M., Reza-Lopez, S., Ma, D. W., Thompson, L. U., and Ward, W. E. 2009a. Flaxseed does not antagonize the effect of ultra-low-dose estrogen therapy on bone mineral density and biomechanical bone strength in ovariectomized rats. J. Toxicol. Environ. Health A 72:1209-1216.
48. Sacco, S. M., Jiang, J. M., Reza-López, S., Ma, D. W., Thompson, L. U., and Ward, W. E. 2009b. Flaxseed combined with lowdose estrogen therapy preserves bone tissue in ovariectomized rats. Menopause 16:545-554.
49. Saggar, J. K., Chen, J., Corey, P., and Thompson, L. U. 2010a. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways. Mol. Nutr. Food Res. 54:415-425.
50. Saggar, J. K., Chen, J., Corey, P., and Thompson, L. U. 2010b. The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways. Nutr. Cancer 62:532-542.
51. Salari, P., Rezaie, A., Larijani, B., and Abdollahi, M. 2008. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med. Sci. Monit. 14:RA37-RA44. (Pubitemid 351457420)
52. Shen, C. L., Yeh, J. K., Rasty, J., Li, Y., and Watkins, B. A. 2006. Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middleaged male rats. Br. J. Nutr. 95:462-468.
53. Suh, K. S., Koh, G., Park, C. Y., Woo, J. T., Kim, S. W., Kim, J. W., Park, I. K., and Kim, Y. S. 2003. Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry 63:209-215. (Pubitemid 36560140)
54. Sun, D., Krishnan, A., Zaman, K., Lawrence, R., Bhattacharya, A., and Fernandes, G. 2003. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J. Bone Mineral Res. 18:1206-1216. (Pubitemid 37294913)
55. Thompson, L. U., Boucher, B. A., Liu, Z., Cotterchio, M., and Kreiger, N. 2007. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr. Cancer 54:184-201. (Pubitemid 44316301)
56. Thompson, L. U., Robb, P., Serraino, M., and Cheung, F. 1991. Mammalian lignan production from various foods. Nutr. Cancer 16:43-52.
57. Thompson, L. U. 2003. Flaxseed, lignans, and cancer. In Flaxseed in human nutrition, 2nd ed., ed. L. U. Thompson and S. C. Cunnane, 194-222. Champaign, IL: AOCS Press.
58. Truan, J. S., Chen, J. M., and Thompson, L. U. 2010. Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen. Mol. Nutr. Food Res. 54:1414-1421.
59. Wang, L., Chen, J., and Thompson, L. U. 2005. The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenograftsis attributed to both its lignan and oil components. Int. J. Cancer 116:793-798. (Pubitemid 41099712)
60. Weiler, H. A., Kovacs, H., Nitschmann, E., Bankovic-Calic, N., Aukema, H., and Ogborn, M. 2007. Feeding flaxseed oil but not secoisolariciresinol diglucoside results in higher bone mass in healthy rats and rats with kidney disease. Prostaglandins Leukotrienes Essential Fatty Acids 76:269-275. (Pubitemid 46813225)
61. Westerlind, K. C., Gibson, K. J., Malone, P., Evans, G. L., and Turner, R. T. 1998. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J. Bone Mineral Res. 13:1023-1031. (Pubitemid 28265281)